Discoveries in Health Policy

Ideas for or from an evolving healthcare system

Friday, March 20, 2026

Can AI Re-Think Health Policy? Example Using WSJ Policy Essay (& MolDx)

›
Can AI read an article and project its possible applications into a different field?  That's today's question.  Starting point: WSJ ...
Thursday, March 19, 2026

NCCN Recommends NGS in All Stages of Pancreatic Cancer: Direct Conflict with Outdated Medicare NCD

›
Tuesday, I was in a webinar where stakeholders were discussing the badly-outdated Medicare NCD for NGS testing in cancer.  Thursday of the s...
Tuesday, March 17, 2026

Waiv (Former Owkin Dx) Brings In $33M For AI Precision Diagnostics

›
It's not every day you hear of a new $33M going into spatial diagnostics - but it happened this week. WAIV Diagnostics, Paris (former Ow...

Illumina Publishes "Diagnostics Year in Review" CY2025 (48pp)

›
 Once again Illumina has published its Diagnostics Year in Review.   See CY2025 in a birdseye view, edited by Mara Aspinall, 48pp. https://w...

BLOODPAC Releases Webinar and White Paper: New Frontiers in Therapy Selection / Beyond DNA Mutations

›
BLOODPAC offered a multi speaker seminar last fall on the topic, New Frontiers in Therapy Selection: Beyond DNA Mutations.  Find the online ...
Saturday, March 14, 2026

Chris Klomp Now Near Top of HHS; See His One-Hour Recent Interview

›
Wall Street Journal, Politico, Washington Post have all been covering the shake-up in senior management at HHS - here .    Chris Klomp rises...

The Strange Place of FIT Testing Between FDA Label and Medicare Screening

›
 Header:  CMS is reviewing its coverage standards for CRC screening biomarkers - stool, blood, etc.   But CMS explicitly will  ignore fitti...

WSJ: White House Shakes Up HHS Management

›
 Per the WSJ March 13 and 14, White House has multiple pathways for "shaking up HHS" at the top management level. https://www.wsj....
Friday, March 13, 2026

Mapping the Colorectal Cancer Screening Proposal: Why Use an Efficiency Frontier

›
CMS has a current NCD for biomarker CRC screening, using 74% sensitivity and 90% specificity as a benchmark.  This means you pick up about 3...

AI History You Can Use: MACs, BCBS Plans, Corporate Structures in Review

›
There are many complex relationships among Medicare contractors, Blues plans, holding entities, novelty names (Elevance), and more.   Chat G...
Thursday, March 12, 2026

AI History You Can Use: Relive Amazing 2007-2010 Debates about FDA, LDT, CDX

›
In the past couple years, we've lived through FDA regulation of LDTs, court cases, and expanding capabilities of genomic diagnostics, ma...
Tuesday, March 10, 2026

CMS Posts New Idea for Colorectal Screening Biomarkers - But Should Use an Equivalence Frontier

›
Update - I walk through the  old and new SENS-SPEC spaces, graphically, here .  ### On March 10, 2026, CMS released a new proposal for cov...

The CRUSH Initiative and Medicare's Bone-Headed Stupid Payments for 81408 and Other Insane Codes

›
In June 2023, OIG published that Medicare's highest paid genomic test code, 81408, was likely unbelievable and fraudulent from day 1.   ...
Monday, March 9, 2026

TriCon: Cutting Edge Conference in SF, May 4-5, 2026

›
The conference TRICON is in its 33rd year, and will be held in San Francisco May 4-5, 2026.  The conferences has three main tracks, "Di...

State Biomarker Bills: Germline Cancer Risk Edition; Plus USPSTF News

›
The breast cancer advocacy foundation, Susan G Komen for the Cure , is actively promoting the need for copay-free germline breast cancer ris...
›
Home
View web version

About the Author

My photo
Bruce
Bruce Quinn MD PhD is an expert on health reform, innovation, and Medicare policy. He helps both large and small companies understand and overcome hurdles to commercialization, as well as craft business strategies for a changing environment. CONTACT Dr. Quinn through www.brucequinn.com. BACKGROUND: Dr. Quinn has worked in academic medicine, Accenture business strategies, and for the Medicare program. EDUCATION: Stanford MD/PhD, MIT Postdoc, Kellogg MBA.
View my complete profile
Powered by Blogger.